Plavix Settlement Updated To Appease FTC
In a case that could influence how the U.S. Federal Trade Commission rules on future settlement agreements over generic drugs, Bristol-Myers Squibb, Sanofi-Aventis and Apotex have altered their settlement over the...To view the full article, register now.
Already a subscriber? Click here to view full article